Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-05-06T15:52:28.166Z Has data issue: false hasContentIssue false
  • English
  • Français

On the venom of the lesser weeverfish, Trachinus vipera

Published online by Cambridge University Press:  11 May 2009

D. B. Carlisle
D. B. Carlisle
Affiliation:
The Plymouth Laboratorycor1corresp
*
Get access Rights & Permissions [Opens in a new window]

Summary

A method is described for obtaining the venom from the dorsal fin of the lesser weever without harming the fish. It is suggested that the amount of venom normally injected into the wound by the weever when it stings is O-5-O-2 mg dry weight of venom. Some 60% of the dry weight of the venom appears to consist of toxic muco-substances, which have a neurotoxic effect, but are without toxic effect on the blood. In extracts this fraction may be separated into two albumins and an amino polysaccharide, though in the native venom these are probably associated into a single complex mucosubstance. When injected subcutaneously this fraction of the venom produces no local pain. The venom also contains about 1-20 jug/mg (dry-weight basis) of 5-hydroxytryptamine which appears to be the origin of the pain of the sting, together with some undetermined histamine releaser (not an indole) of low molecular weight. It is suggested that the chief role of the 5-hydroxytryptamine in the venom is to produce pain around the area of the inflicted wound.

Type
Research Article
Information
Journal of the Marine Biological Association of the United Kingdom , Volume 42 , Issue 2 , June 1962 , pp. 155 - 162
Copyright
Copyright © Marine Biological Association of the United Kingdom 1962

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adam, K. R. & Weiss, C., 1956. 5-hydroxytryptamine in scorpion venom. Nature, Lond., Vol. 178, pp. 421–2.CrossRefGoogle ScholarPubMed
Adam, K. R. & Weiss, C., 1958. The occurrence of 5-hydroxytryptamine in scorpion venom. J. exp. Biol., Vol. 35, pp. 39–42.CrossRefGoogle Scholar
Adam, K. R. & Weiss, C., 1959. Distribution of 5-hydroxytryptamine in scorpion venom. Nature, Lond., Vol. 183, pp. 1398–9.CrossRefGoogle Scholar
Armstrong, D., Dry, R. M. L., Keele, C. A. & Markham, J. W., 1953. Observations on chemical excitants of cutaneous pain in man. J. Physiol., Vol. 120, pp. 326–51. The British Pharmacopeia, 1948. London.Google Scholar
Collier, H. O. J. & Chesher, G. B. 1956. Identification of 5-hydroxytryptamine in the sting of nettle (Urtica dioica). Brit. J. Pharmacol., Vol. II.Google Scholar
Erspamer, V., 1954. Pharmacology of indolealkylamines. Pharmacol. Rev., Vol. 6, pp. 425–87.Google ScholarPubMed
Jacques, R. & Schachter, M., 1954. The presence of histamine, 5-hydroxytryptamine and a potent slow-contracting substance in wasp venom. Brit. J. Pharmacol., Vol. 9, pp. 53–8.Google Scholar
Kent, P. W. & Whitehouse, M. W., 1955. Biochemistry of Amino Sugars. London.Google Scholar
Page, I. H. 1958. Serotonin (5-hydroxytryptamine); the last four years. Physiol. Rev., Vol. 38, pp. 277–335.CrossRefGoogle ScholarPubMed
Russell, F. E. & Emery, J. A., 1960. Venom of the weevers Trachinus draco and Trachinus vipera. Ann. N.Y. Acad. Sci., Vol. 90, pp. 805–19.Google Scholar
Welsh, J. H., 1960. 5-hydroxytryptamine in coelenterates. Nature, Lond., Vol. 186, pp. 811–12.Google Scholar
Welsh, J. H. & Moorhead, M., 1960. The quantitative distribution of 5-hydroxytryptamine in the invertebrates, especially in their nervous systems. J. Neurophysiol., Vol. 6, pp. 146–69.Google Scholar